• Navigation überspringen
  • Zur Navigation
  • Zum Seitenende
Organisationsmenü öffnen Organisationsmenü schließen
Logo of the
  • FAUZur zentralen FAU Website
  1. Friedrich-Alexander-Universität
  2. Technische Fakultät
  3. Department Chemie- und Bioingenieurwesen
  • Campo
  • UnivIS
  • Stellenangebote
  • Lageplan
  • Hilfe im Notfall
  1. Friedrich-Alexander-Universität
  2. Technische Fakultät
  3. Department Chemie- und Bioingenieurwesen

Logo of the

Menu Menu schließen
  • About Us
    • Staff
    • Open Positions
    • Graduation
    • Our Labs
    • Contact
    Portal About Us
  • Research
    • Research Groups
    • Collaborations
    • Publications
    Portal Research
  • Teaching
    • Lectures
    • Scientific Talks
    Portal Teaching
  1. Startseite
  2. Research
  3. Research Groups
  4. Malaria Biotechnology

Malaria Biotechnology

Bereichsnavigation: Research
  • Research Groups
    • Muscle Opto-Biomechatronics
      • The MyoRobot
      • The MechaMorph
      • The IsoStretcher
      • Virtual Laboratory
    • Malaria Biotechnology
      • RG Protein Engineering
      • Metabolic enzymes as drug targets
      • Identification of novel antimalarial compounds
      • Mitosis as drug target
      • Identification of transporters of the MGC-basic proteins
      • Characterization of drug-resistance transporters of the digestive vacuole
      • Malaria vaccine directed against blood stages
    • Tissue Engineering
      • Bone Tissue Engineering
      • Research Topic 2 (TE)
      • Research Topic 3 (TE)
    • Optical Technologies in Life Sciences
      • Label-free Multiphoton Imaging
      • Multiphoton Endomicroscopy for Life Science and Medicine
      • Raman Spectroscopy of Biological Tissue
      • PiezoGRIN: Multiphoton Imaging under high Pressures
    • High-throughput Biology & Robophotonics
      • High-throughput Biology & Functional Neurogenomics
      • Robophotonics & Rapid Prototyping
  • Collaborations
  • Publications

Malaria Biotechnology

Group Leader

Barbara Kappes

Prof. Dr. Barbara Kappes

Group Leader

Medical Biotechnology
Malaria Biotechnology

Raum: Room 01.020
Paul-Gordan-Str. 3
91052 Erlangen
Germany
  • Telefon: +49913185-23299
  • E-Mail: barbara.kappes@fau.de
  • Webseite: https://www.mbt.tf.fau.de/

Related Research Group

  • RG Protein Engineering

Selected Research Topics

  • Metabolic enzymes as drug targets
  • Identification of novel antimalarial compounds
  • Mitosis as drug target

Malaria is responsible for the deaths of about 445,000 people each year (WHO Report 2017), with increasing tendency. With about 216 million cases per year, the victims are mostly children under the age of five years. Drug-resistances against all commercially available antimalarial drugs have been reported for Plasmodium falciparum parasites. The only vaccine on the market has an efficacy of only 20‑30%. Thus, there is an urgent need to identify new drug targets and novel antimalarial drugs to defeat the disease.

Our main research topics focus on metabolic regulations involving the pyridoxal phosphate synthase 1 (PfPdx1), an enzyme jointly responsible for the parasite vitamin B6 synthesis with PfPdx2, the identification of essential protein transporters and cell division of the malaria parasite. Our PC1 and PC2 laboratories are located in the Ulrich-Schalk-Str. 3 and are equipped with devices allowing a variety of gentechnological, protein biochemical and cell biological techniques. We currently focus on the identification of protein-protein interactions, enzymatic assays with recombinantly produced proteins and in vivo microscopy with living cells or fixed malaria parasites. All our investigations aim at a better understanding of molecular mechanisms that are vital for parasite survival.

Friedrich-Alexander-Universität
Erlangen-Nürnberg

Schlossplatz 4
91054 Erlangen
  • Imprint
  • Privacy
  • Accessibility
Nach oben